Tesla Earnings Follow Musk's Take-It-or-Leave-It Twitter Bid
Our preview of the upcoming week's earnings reports includes Tesla (TSLA), Johnson & Johnson (JNJ) and Netflix (NFLX).
First-quarter earnings season starts to heat up this week. Among the notable names on the earnings calendar are electric carmaker Tesla (TSLA, $986.01), pharmaceutical giant Johnson & Johnson (JNJ, $180.05) and streaming name Netflix (NFLX, $343.38).
Results from JPMorgan Chase (JPM) last week underscored how macro factors are impacting publicly traded corporations. "The firm cited higher probabilities of downside risks driven by the war between Russia and Ukraine as well as elevated inflation," says Dan Eye, chief investment officer at asset manager Fort Pitt Capital Group.
"It feels like there is more uncertainty heading into this quarter's earnings season than there has been in some time," says Michael Reinking, senior market strategist at the New York Stock Exchange.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
While Reinking expects first-quarter earnings to remain strong, guidance will likely fall on the conservative side.
"Investors will be looking to conference calls for a better understanding of how the environment is shaping up," Reinking adds. "The margin story will remain a focal point with the main questions centered around whether price increases have been tolerated, are they impacting demand and has that changed in the back half of the quarter as the consumer is now getting hit on multiple fronts."
Tesla Earnings to Show Strong YoY Growth
Oppenheimer analyst Colin Rusch (Outperform) thinks Tesla's ability to pass on higher supply-chain costs to consumers will help drive margins for the automaker. The company has "substantial pricing power," Rusch says, "as demonstrated on recent price increases across models and commentary that the company is sold out through the end of the year in certain geographies."
It's already been a busy news cycle for Tesla. In addition to headlines signaling a potential second TSLA stock split in just two years, CEO Elon Musk followed up reports that he took a sizable stake in Twitter (TWTR) with an offer to buy out the microblogging site.
But this week, attention will be back on Tesla's fundamentals, with the company scheduled to report its first-quarter results after Wednesday's close.
Earlier this month, the company said it delivered more than 310,000 in the first three months of the year. "TSLA's growth stands in stark contrast to other automakers who posted steep declines in U.S. sales in Q1," says CFRA Research analyst Garrett Nelson. He adds that the startup of the company's new factories in German and Texas will accelerate deliveries going forward.
The analyst also believes that "supply agreements signed with mining companies position the company to navigate battery raw materials shortages more successfully than competitors." Nelson has a Buy rating on TSLA stock, saying the company's "first-mover and cost of capital advantages, as well as future demand from the rental car and commercial truck markets, remain underappreciated by investors."
For TSLA's first quarter, analysts, on average, are targeting earnings of $2.26 per share – a marked improvement over the 93 cents per share it reported in Q1 2021. On the top line, the consensus estimate is for $17.8 billion, up 71.2% year-over-year (YoY).
Johnson & Johnson Earnings Could Get Hit By Forex Headwinds
Inflation will certainly be in focus when Johnson & Johnson reports its first-quarter earnings report ahead of Tuesday's open.
In JNJ's fourth-quarter earnings call, Chief Financial Officer Joe Wolk acknowledged that the company was "experiencing the impact of inflationary pressures, including higher input costs across our business and more significantly with respect to consumer health." According to Wolk, this included the "availability and cost of certain commodities, labor and transportation."
To counter these cost pressures, the executive said JNJ was initiating price increases across its consumer health portfolio in 2022.
Meanwhile, "The 'macro' has engulfed the med tech narrative and added to the near-term uncertainty," writes Raymond James analyst Jayson Bedford. However, he still sees plenty of demand for the industry.
Bedford has an Outperform (Buy) rating on the Dow Jones stock. He believes the company's "growth profile" is supported by gains in both its pharmaceutical and medical technology segments, as well as the spinoff of its consumer health business.
But he recently lowered his first-quarter revenue and adjusted earnings per share (EPS) estimates (to $23.7 billion and $2.50 per share, respectively) due to forex-related headwinds. Consensus estimates are for Johnson & Johnson to report revenue of $23.7 billion (+7.7% YoY) and earnings of $2.61 per share (+0.8% YoY).
Netflix Price Hikes Could Offset Slowing Subscriber Growth
It's been a rough year for communication services stocks and Netflix is no exception. Shares are off around 43% so far in 2022 to erase all of their pandemic-related gains.
In addition to broad-market headwinds, Netflix has been hampered by slowing subscriber growth. In late January, NFLX stock plunged almost 22% the day after reporting lower year-over-year subscriber additions in the fourth quarter and guiding for even slower growth in the first quarter.
And this metric was likely pressured even more so after Netflix joined the growing list of companies pulling out of Russia by suspending service in the country.
Still, Netflix's "first-mover advantage and large subscriber base provides the company with a nearly insurmountable competitive advantage over its streaming peers," says Wedbush analyst Michael Pachter (Neutral). He adds that the firm's mid-January price hikes on U.S. plans will offset slowing user growth.
NFLX will unveil its first-quarter earnings report after April 19 close. Analysts, on average, are looking for earnings of $2.90 per share (-22.3% YoY) and revenue of $7.9 billion (+10.7% YoY).
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Will President Trump's Medicare Executive Order Raise Drug Prices?
President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare enrollees.
By Donna Fuscaldo Published
-
Stock Market Today: Dow Adds 538 Points on First Trading Day of Second Trump Administration
Stocks rise while the White House issues a historic series of executive orders.
By David Dittman Published
-
Stock Market Today: Dow Adds 538 Points on First Trading Day of Second Trump Administration
Stocks rise while the White House issues a historic series of executive orders.
By David Dittman Published
-
Stock Market Today: Stocks Pause After a Big Rally
The Nasdaq continues to lag the S&P 500 and the Dow so far in 2025.
By David Dittman Published
-
Stock Market Today: Stocks Dragged Down by Strong Data
Investors weigh the prospect of no more rate cuts in the current cycle.
By David Dittman Published
-
Stock Market Today: Dow Adds 340 Points to End Skid
The S&P 500 closed the official Santa Claus rally period down 0.5%.
By David Dittman Published
-
Stock Market Today: Stocks Start the New Year With a Hangover
Equities continued their post-holiday slide as investors fled risk assets.
By Dan Burrows Published
-
Stock Market Today: Dow Sinks 333 Points as Mega Caps Slide
The main indexes sold off at the open and stayed lower through the close, putting the Santa Claus rally at risk.
By Karee Venema Published
-
Stock Market Today: Stocks Soar to Start the Santa Claus Rally
All three main equity indexes flew like the down of a thistle on Christmas Eve.
By David Dittman Published
-
Stock Market Today: Stocks Advance on Light Volume Thanks to Big Tech
Equities rose in a mostly sleepy session as Mag 7 names led the way.
By Dan Burrows Published